Dual block with lapatinib and trastuzumab versus single agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: a meta-analysis of randomized trials

Authors
Publication date
1 January 2016
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio Istituzionale della Ricerca- Università del Piemonte Orientale

    redirect
    oaioai:iris.uniupo.it:11579/93229
    Last time updated on 03/09/2019